Case Studies

Every drug development journey encounters challenges—but the right expertise can make all the difference. At KreaMedica, we help teams navigate complexity, manage risk, and keep timelines on track. Our flexible, proactive support has helped clients solve problems across toxicology, bioanalytics, and preclinical development—learn how we can help you do the same.

Cairn header scaled

How KreaMedica Enabled Cost-Effective, Remote Toxicology Studies for Cairn Therapeutics

[short_description_excerpt]

Cairn Therapeutics is a pharmaceutical company with a mission to help patients beat cancer. Its team is developing a novel drug for solid tumors and

Adamed header 1 scaled

Knowing When to Let Go of a Project: A Case Study with Adamed Pharma

[short_description_excerpt]

Adamed Pharma is a leading pharmaceutical and biotechnology company, with over 900 products and 256 patents covering 19 therapeutic areas. It was the first Polish

Ron Wolff scaled

Building Lasting Biotech Partnerships: An Interview with Ron Wolff of RK Wolff Safety Consulting

[short_description_excerpt]

Ron Wolff, president of RK Wolff Safety Consulting Inc. and former Vice President of Regulatory Affairs & Toxicology at Pulmokine, is a long-time collaborator of

1 scaled

N-Zyme’s Path to the Clinic

[short_description_excerpt]

Franco Vigile had recently sold the genetic-based pre-screening company he founded and was in Mexico celebrating when he woke up one morning unable to swallow.